tiprankstipranks
Talphera enrolls first patient in NEPHRO CRRT study
PremiumThe FlyTalphera enrolls first patient in NEPHRO CRRT study
7M ago
Talphera price target lowered to $3.50 from $4.25 at Alliance Global Partners
Premium
The Fly
Talphera price target lowered to $3.50 from $4.25 at Alliance Global Partners
7M ago
Talphera Announces CMO Retirement and Successor Appointment
Premium
Company Announcements
Talphera Announces CMO Retirement and Successor Appointment
7M ago
Talphera, Inc. Is Worried About This – Should You Be Worried Too?
PremiumCompany AnnouncementsTalphera, Inc. Is Worried About This – Should You Be Worried Too?
12M ago
Talphera sees cash runway sufficient to reach potential Niyad approval in 2Q25
Premium
The Fly
Talphera sees cash runway sufficient to reach potential Niyad approval in 2Q25
12M ago
Talphera reports Q4 EPS (25c) vs. ($1.00) last year
Premium
The Fly
Talphera reports Q4 EPS (25c) vs. ($1.00) last year
12M ago
Talphera announces $26M capital commitment
PremiumThe FlyTalphera announces $26M capital commitment
1y ago
Xoma expands commercial royalty, milestone portfolio with DSUVIA acquisition
Premium
The Fly
Xoma expands commercial royalty, milestone portfolio with DSUVIA acquisition
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100